Skip to content

R&D at other companies

Intuitive Surgical logo
Intuitive SurgicalISRG
$361.9M+14.5%
Medtronic logo
MedtronicMDT
$671M-1.9%
AngioDynamics logo
AngioDynamicsANGO
$7.08M+2.5%
ITG
Integer HoldingsITGR
$16.24M+14.4%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$22.61M+0.6%
Stereotaxis logo
StereotaxisSTXS
$2.4M+2.0%

Other financials

Income statement

See full
Revenue$105.0K
Gross profit$2.0K
Operating income-$4.3M-43.0%
Net income-$3.7M-41.1%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$3.7M+13.7%
Total debt$898.0K+551%
Total equity$74.1M+156%
Total assets$78.1M+153%

Cash flow

See full
Operating cash flow-$5.1M-75.8%
CapEx$108.0K+731%
Free cash flow-$5.2M-78.8%

Valuation

See full
Market cap$128.28M+36.1%
Enterprise value$125.53M+39.0%
P/S674.3×

Profitability

See full
Operating margin25,292.9%
Net margin-3,669.9%
FCF margin-852.8%

Returns & leverage

See full
Return on equity-27.6%-10.2pp
Debt / equity0.0×
Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Microbot Medical's R&D?
Microbot Medical (MBOT) reported R&D of $1.29M in Q1 2026.
How has Microbot Medical's R&D changed year-over-year?
Microbot Medical's R&D decreased by 11.4% year-over-year, from $1.46M to $1.29M.
What is the long-term trend for Microbot Medical's R&D?
Over 4 years (2021 to 2025), Microbot Medical's R&D has grown at a 0.5% compound annual growth rate (CAGR), from $6.15M to $6.28M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.